New cancer clinical trial: ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

Published on: March 29, 2018 at 12:00PM
Condition:   Metastatic Castration Resistant Prostate Cancer (mCRPC)
Interventions:   Drug: CPI-1205;   Drug: Enzalutamide;   Drug: Abiraterone/Prednisone
Sponsor:   Constellation Pharmaceuticals
Recruiting
https://ift.tt/2Ikawg3